Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Celebrex

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Celebrex was produced by Pfizer.

Not in my backyard

Not in my backyard

But what happens when US wholesalers and licensed pharmacies start buying up Celebrex for less than $200 and then reselling it for a nominal discount - say $795 instead of $895?

Products over pipeline in Pfizer's acquisition targets, hints CEO

Products over pipeline in Pfizer's acquisition targets, hints CEO Most damaging to Pfizer's top-line this year was the loss of patent protection for big-selling painkiller Celebrex  (celecoxib) last December in the US, with competition already being felt

Immunocore names CEO

Immunocore names CEO During this time he helped bring several drugs to markets including Celebrex (celecoxib) and Relpax (eletriptan) and to establish the company in India and China.

Pfizer 2014 guidance threatened by Celebrex competition

Pfizer 2014 guidance threatened by Celebrex competition Celebrex sales were a little over $2.9bn last year, with $1.9bn of that total coming from the US market. ... Pfizer's recently-issued financial guidance for 2014 is based on a full year of Celebrex sales, according to chief financial officer Frank

Who tops the pharma list?

Who tops the pharma list? year. With many more to come, including - in the next 12 months expiries on Sanofi's Lantus (2012 sales of $6.5bn), Pfizer's Celebrex ($2.7bn) and AZ's Nexium (

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics